The DOI matches its Crossref record; 1,858 of the 1,862 references it cites were found in a registry or an index.
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Open accessAbstract
This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested, zonated lobules, the liver consists of approximately 80 % hepatocytes and 20 % non-parenchymal cells, the latter being involved in a secondary phase that may dramatically aggravate the initial damage. Hepatotoxicity, as well as hepatic metabolism, is controlled by a set of nuclear receptors (including PXR, CAR, HNF-4α, FXR, LXR, SHP, VDR and PPAR) and signaling pathways. When isolating liver cells, some pathways are activated, e.g., the RAS/MEK/ERK pathway, whereas others are silenced (e.g. HNF-4α), resulting in up- and downregulation of hundreds of genes. An understanding of these changes is crucial for a correct interpretation of in vitro data. The possibilities and limitations of the most useful liver in vitro systems are summarized, including three-dimensional culture techniques, co-cultures with non-parenchymal cells, hepatospheres, precision cut liver slices and the isolated perfused liver. Also discussed is how closely hepatoma, stem cell and iPS cell-derived hepatocyte-like-cells resemble real hepatocytes. Finally, a summary is given of the state of the art of liver in vitro and mathematical modeling systems that are currently used in the pharmaceutical industry with an emphasis on drug metabolism, prediction of clearance, drug interaction, transporter studies and hepatotoxicity. One key message is that despite our enthusiasm for in vitro systems, we must never lose sight of the in vivo situation. Although hepatocytes have been isolated for decades, the hunt for relevant alternative systems has only just begun.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures








![Fig. 9 Antiproteolytic effect of acetaldehyde in the single pass perfused rat liver. a Acetaldehyde (5 mmol/l) was infused into the perfused liver for 30 min, and the release of [3H]leucine from pre-labeled rats was taken as a measure of proteolysis. b The resulting inhibition of proteolysis under steady-state conditions at different concentrations of acetaldehyde. Data are from 2 to 4 different experiments and are given as mean ± SEM. From vom Dahl and Häussinger (1998)](/paper-figures/2844bb4a493e46429af445399835e22f/recent-advances-in-2d-and-3d-in-vitro-systems-using-primary-hepatocytes-figure-9.jpg)
















































Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Already in the first few days of cultivation, a reduction of hepatic functions can be observed, e.g. production of plasma proteins, drug metabolizing enzyme activities, glucose metabolism and urea synthesis (Godoy et al., 2013[15]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Primary human hepatocytes (PHHs) are an important tool for studying human liver disease and drug-induced liver injury (DILI), with other models, such as rat hepatocytes, hepatic cell lines and stem cell-derived hepatocyte-like cells failing to offer metabolically competent and species-relevant alternatives (Godoy et al. 2013).”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In fact, zonation appears to be a large influencing factor on variation during culture as our pathway analysis of the most variable proteins revealed significant association with ketogenesis, cholesterol biosynthesis, fatty acid β oxidation and glutamine synthesis (table S4), all of these are related to the portocentral axis gradient of the lobule (Godoy et al. 2013).”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“although cytotoxicity measures are fundamental in the assessment of a drug’s potential for hepatotoxicity in vitro33,34, gene expression and various phenotypic changes can occur at much lower concentrations35,36.”
From Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology (2022) · cites this paper as [34]
The cited source says what the claim attributes to it.
In the citing paper
“The apical membrane is equipped with transport proteins that eliminate bile acids and xenobiotics from the cell, like multidrug resistance-associated protein 2 (MRP2) (Godoy et al., 2013[15]; Ito et al., 2005[20]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“The hepatocyte's basal membrane faces the sinusoid. It expresses several transmembrane transporters that manage the exchange of substances with the sinusoidal blood stream (Godoy et al., 2013[15]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“In vivo, the distribution of ECM components varies between the different parts of the liver acinus, the smallest organizational unit of the liver (Godoy et al., 2013[15]; Martinez-Hernandez and Amenta, 1993[26]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“The application of primary human hepatocytes following isolation from human tissue is well accepted to be compromised by the process of dedifferentiation.”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In practice, strategies for optimizing HepG2 can be divided into several approaches. The first approach is based on genetic modification of cells to express key biotransformation enzymes, in particular cytochrome P450 isoforms [109]. The second approach involves epigenetic and cultural maturation of cells, which allows for increased expression of nuclear receptors and, consequently, of xenobiotic”
From The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease (2026) · cites this paper as [163]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Wheat proteins improve cryopreservation of rat hepatocytes
Grondin, M., Hamel, F., Averill‐Bates, D. A., & Sarhan, F. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22270 · Cited by 18
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Computer Simulation of Liquids
Allen, M. P., & Tildesley, D. J. (2017) · doi:10.1093/oso/9780198803195.001.0001 · Cited by 20,945
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Computer Simulation of Liquids
P, S., & J, K. (1988) · Journal of Molecular Liquids · doi:10.1016/0167-7322(88)80022-9 · Cited by 16,088
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,673
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Two-photon laser scanning fluorescence microscopy
Denk, W., Strickler, J. H., & Webb, W. W. (1990) · Science · doi:10.1126/science.2321027 · Cited by 9,488
Research works printed but not linked: 9
- Bode JG (2011) Inflammation and liver regeneration. In: Häussinger D (ed) Liver regneration. DeGruyter Verlag, Berlin
- Bücher T, Sies H (1976) Mitochondrial and cytosolic redox states in perfused rat liver: methods and problems in metabolic compartmentation. In: Tager jm WJ, Söling D (eds) Use of isolated liver cells and kidney tubules in metabolic studies. North Holland Publishing Company/American Elsevier, New York/Amsterdam
- EPA (2012) EPA’s reanalysis of key issues related to dioxin toxicity and response to NAS Comments. Environmental Protection Agency (EPA), Washington, DC
- Hallifax D, Foster JA, Houston JB (2010) Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view. Pharm Res 27:2150–2161 · DOI
- ITC (International Transporter Consortium) (2010) Membrane transporters in drug development (Report from the FDA Critical Path Workshop). Nat Rev Drug Discov 9:215–236 · DOI · Paper page
- Lamers W, Moorman A, Charles R (1989) The metabolic lobulus, a key to the architecture of the liver. In: Revisiones Sobre Biologia Celular, Springer, New York
- Sahin S (2003) Perfused liver preparation and its applications. FABAD J Pharm Sci 28:39–49
- Waddington CH (1942) The epigenotype. Endeavour 1:18–20
- Warburg O (1923) Versuche an überlebendem Karzinomgewebe. Biochem Z 142:317
Cited by
Sorted by citations
Items 101–200 of 1,002
Godoy, P., Widera, A., Schmidt‐Heck, W., Campos, G., Meyer, C., Cadenas, C., Reif, R., Stöber, R. M., Hammad, S., Pütter, L., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1761-4 · Cited by 109
Self-citationAccessing 3D microtissue metabolism: Lactate and oxygen monitoring in hepatocyte spheroids
Weltin, A., Hammer, S., Noor, F., Kaminski, Y., Kieninger, J., & Urban, G. A. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.07.094 · Cited by 106
Ware, B. R., Durham, M., Monckton, C. P., & Khetani, S. R. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.11.007 · Cited by 106
Pfeiffer, E., Kegel, V., Zeilinger, K., Hengstler, J. G., Nussler, A. K., Seehofer, D., & Damm, G. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214558025 · Cited by 111
Self-citationXuan, J., Chen, S., Ning, B., Tolleson, W. H., & Guo, L. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.10.009 · Cited by 103
Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells
Chen, C., Soto–Gutiérrez, A., Baptista, P. M., & Spee, B. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.066 · Cited by 108
Hepato(Geno)Toxicity Assessment of Nanoparticles in a HepG2 Liver Spheroid Model
Elje, E., Mariussen, E., Moriones, O. H., Bastús, N. G., Puntes, V., Kohl, Y., Dušinská, M., & Rundén‐Pran, E. (2020) · Nanomaterials · doi:10.3390/nano10030545 · Cited by 103
Davidson, M. D., Ballinger, K. R., & Khetani, S. R. (2016) · Scientific Reports · doi:10.1038/srep28178 · Cited by 100
Prestigiacomo, V., Weston, A. A., Messner, S., Lampart, F. L., & Suter‐Dick, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179995 · Cited by 102
Self-citationStandardizing chromatin research: a simple and universal method for ChIP-seq
Arrigoni, L., Richter, A. S., Betancourt, E., Bruder, K., Diehl, S., Manke, T., & Bönisch, U. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1495 · Cited by 99
Loss of liver function in chronic liver disease: An identity crisis
Berasain, C., Arechederra, M., Argemí, J., Fernández-Barrena, M. G., & Avila, M. A. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2022.09.001 · Cited by 99
Bile Acid-Activated Receptors: GPBAR1 (TGR5) and Other G Protein-Coupled Receptors
Keitel, V., Stindt, J., & Häussinger, D. (2019) · Handbook of Experimental Pharmacology · doi:10.1007/164_2019_230 · Cited by 98
Self-citationOn-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro
Jang, M., Neužil, P., Volk, T. J., Manz, A., & Kleber, A. (2015) · Biomicrofluidics · doi:10.1063/1.4922863 · Cited by 100
Comparing in vitro human liver models to in vivo human liver using RNA-Seq
Gupta, R., Schrooders, Y., Hauser, D. A., van Herwijnen, M. H. M., Albrecht, W., ter Braak, B., Brecklinghaus, T., Castell, J. V., Elenschneider, L., Escher, S. E., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02937-6 · Cited by 98
Self-citationJayasuriya, R., Umapathy, D., Ali, D., Ganesan, K., Xu, B., & Ramkumar, K. M. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153755 · Cited by 95
Shedding light on 3D printing: Printing photo-crosslinkable constructs for tissue engineering
Zhang, Q., Bei, H., Zhao, M., Dong, Z., & Zhao, X. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121566 · Cited by 95
Bonn, B., Svanberg, P., Janefeldt, A., Hultman, I., & Grime, K. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.067769 · Cited by 93
Feng, D., Xiang, X., Guan, Y., Guillot, A., Lu, H., Chang, C., He, Y., Wang, H., Pan, H., Ju, C., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166954 · Cited by 93
Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail
Berger, B., Donzelli, M., Maseneni, S., Boess, F., Roth, A. B., Krähenbühl, S., & Haschke, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00443 · Cited by 92
Functional properties of hepatocytes in vitro are correlated with cell polarity maintenance
Zeigerer, A., Wuttke, A., Marsico, G., Seifert, S., Kalaidzidis, Y. L., & Zerial, M. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.11.027 · Cited by 91
Soto–Gutiérrez, A., Gough, A., Vernetti, L. A., Taylor, D. L., & Monga, S. P. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217707731 · Cited by 94
Videla, L. A., & Valenzuela, R. (2021) · BioFactors · doi:10.1002/biof.1797 · Cited by 91
All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells
Werner, M., Driftmann, S., Kleinehr, K., Kaiser, G. M., Mathé, Z., Treckmann, J. W., Paul, A., Skibbe, K., Timm, J., Canbay, A. E., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138655 · Cited by 95
Klein, M., Thomas, M., Hofmann, U., Seehofer, D., Damm, G., & Zanger, U. M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.060962 · Cited by 90
Self-citationWilk–Zasadna, I., Bernasconi, C., Pelkonen, O., & Coecke, S. (2014) · Toxicology · doi:10.1016/j.tox.2014.10.006 · Cited by 94
Wink, S., Hiemstra, S. W., Huppelschoten, S., Danen, E. H. J., Niemeijer, M., Hendriks, G., Vrieling, H., Herpers, B., & van de Water, B. (2014) · Chemical Research in Toxicology · doi:10.1021/tx4004038 · Cited by 93
Signaling pathways of oxidative stress in aquatic organisms exposed to xenobiotics
Silvestre, F. (2020) · Journal of Experimental Zoology Part A Ecological and Integrative Physiology · doi:10.1002/jez.2356 · Cited by 89
Gómez‐Lechón, M. J., Tolosa, L., & Donato, M. T. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3277 · Cited by 87
Self-citationMandon, M., Huet, S., Dubreil, E., Fessard, V., & Hégarat, L. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-47114-7 · Cited by 93
Zimmer, B., Pallocca, G., Dreser, N., Foerster, S., Waldmann, T., Westerhout, J., Julien, S., Krause, K., van Thriel, C., Hengstler, J. G., et al. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1231-9 · Cited by 86
Self-citationSandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury
Yang, K., Guo, C., Woodhead, J. L., Claire, R. L. S., Watkins, P. B., Siler, S. Q., Howell, B. A., & Brouwer, K. L. R. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.008 · Cited by 86
Tripathi, A., & Melo, J. S. (2015) · RSC Advances · doi:10.1039/c5ra04153h · Cited by 88
Stem-cell based organ-on-a-chip models for diabetes research
Rogal, J., Zbinden, A., Schenke‐Layland, K., & Loskill, P. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.010 · Cited by 89
Liver Tissue Engineering: Challenges and Opportunities
Agarwal, T., Subramanian, B., & Maiti, T. K. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00745 · Cited by 83
Nono, J. K., Fu, K., Mpotje, T., Varrone, G., Aziz, N. A., Mosala, P., Hlaka, L., Kamdem, S. D., Xu, D., Spangenberg, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67514-4 · Cited by 83
Drug metabolic stability in early drug discovery to develop potential lead compounds
Gajula, S. N. R., Nadimpalli, N., & Sonti, R. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1970178 · Cited by 83
Kermanizadeh, A., Løhr, M., Roursgaard, M., Messner, S., Gunness, P., Kelm, J. M., Möller, P., Stone, V., & Loft, S. H. (2014) · Particle and Fibre Toxicology · doi:10.1186/s12989-014-0056-2 · Cited by 82
Self-citationOlsen, T. R., Ng, K. S., Lock, L. T., Ahsan, T., & Rowley, J. A. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00178 · Cited by 85
Park, H., Choi, Y.-J., Kim, J. W., Chun, H., Im, I., Yoon, S., Han, Y., Song, C.-W., & Kim, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132992 · Cited by 82
Self-citationPrediction of Drug Clearance and Drug-Drug Interactions in Microscale Cultures of Human Hepatocytes
Lin, C., Shi, J., Moore, A., & Khetani, S. R. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.066027 · Cited by 80
Scaffold‐Free Liver‐On‐A‐Chip with Multiscale Organotypic Cultures
Weng, Y., Chang, S., Shih, M., Tseng, S., & Lai, C. (2017) · Advanced Materials · doi:10.1002/adma.201701545 · Cited by 81
Hanging Drop, A Best Three-Dimensional (3D) Culture Method for Primary Buffalo and Sheep Hepatocytes
Shri, M., Agrawal, H., Rani, P., Singh, D., & Onteru, S. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-01355-6 · Cited by 80
Tan, K. Y. S., Keegan, P. M., Rogers, M. T., Lu, M., Gosset, J. R., Charest, J. L., & Bale, S. S. (2019) · Lab on a Chip · doi:10.1039/c8lc01262h · Cited by 78
Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives
Kang, S. H., Kim, M. Y., Eom, Y. W., & Baik, S. K. (2020) · Gut and Liver · doi:10.5009/gnl18412 · Cited by 78
Neiman, J. A. S., Raman, R., Chan, V., Rhoads, M. G., Raredon, M. S. B., Velazquez, J. J., Dyer, R. L., Bashir, R., Hammond, P. T., & Griffith, L. G. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25494 · Cited by 78
Messner, S., Fredriksson, L., Lauschke, V. M., Roessger, K., Escher, C., Bober, M., Kelm, J. M., Ingelman‐Sundberg, M., & Moritz, W. (2017) · Applied In Vitro Toxicology · doi:10.1089/aivt.2017.0022 · Cited by 81
Self-citationCoronado, R. E., Somaraki-Cormier, M., Natesan, S., Christy, R. J., Ong, J. L., & Halff, G. A. (2017) · Cell Transplantation · doi:10.1177/0963689717742157 · Cited by 78
Rebelo, S. P., Costa, R., Silva, M. M., Marcelino, P. A., Brito, C., & Alves, P. M. (2015) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2099 · Cited by 77
Kovacsics, D., Patik, I., & Özvegy-Laczka, C. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1253679 · Cited by 73
Towards improved hepatocyte cultures: Progress and limitations
Ruoß, M., Vosough, M., Königsrainer, A., Nadalin, S., Wagner, S., Sajadian, S., Huber, D., Heydari, Z., Ehnert, S., Hengstler, J. G., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111188 · Cited by 77
Self-citationIn vitro metabolic zonation through oxygen gradient on a chip
Tonon, F., Giobbe, G. G., Zambon, A., Luni, C., Gagliano, O., Floreani, A., Grassi, G., & Elvassore, N. (2019) · Scientific Reports · doi:10.1038/s41598-019-49412-6 · Cited by 76
A macrophage-hepatocyte glucocorticoid receptor axis coordinates fasting ketogenesis
Loft, A., Schmidt, S. F., Caratti, G., Stifel, U., Havelund, J., Sekar, R., Kwon, Y., Sulaj, A., Chow, K. K., Alfaro, A. J., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.004 · Cited by 76
Experimental liver models: From cell culture techniques to microfluidic organs‐on‐chip
Polidoro, M. A., Ferrari, E., Marzorati, S., Lleò, A., & Rasponi, M. (2021) · Liver International · doi:10.1111/liv.14942 · Cited by 77
Liver three-dimensional cellular models for high-throughput chemical testing
Yang, S., Ooka, M., Margolis, R. J., & Xia, M. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100432 · Cited by 75
Ardalani, H., Sengupta, S., Harms, V. M., Vickerman, V., Thomson, J. A., & Murphy, W. L. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.07.047 · Cited by 80
Stem Cells for Next Level Toxicity Testing in the 21st Century
Fritsche, E., Haarmann‐Stemmann, T., Kapr, J., Galanjuk, S., Hartmann, J., Mertens, P. R., Kämpfer, A. A. M., Schins, R. P. F., Tigges, J., & Koch, K. (2020) · Small · doi:10.1002/smll.202006252 · Cited by 78
Manco, R., & Itzkovitz, S. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.09.003 · Cited by 80
Lee, B. H., Kim, M. H., Lee, J. H., Seliktar, D., Cho, N., & Tan, L. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118123 · Cited by 75
Mleczko-Sanecka, K., Roche, F., Rita da Silva, A., Call, D., D’Alessio, F., Ragab, A., Lapinski, P. E., Ummanni, R., Korf, U., Oakes, C., et al. (2014) · Blood · doi:10.1182/blood-2013-07-515957 · Cited by 74
Self-citationThe Role of Canalicular ABC Transporters in Cholestasis
Cuperus, F. J. C., Claudel, T., Gautherot, J., Halilbasic, E., & Trauner, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056358 · Cited by 76
Fisher, C., Siméon, S., Jamei, M., Gardner, I., & Bois, Y. F. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.12.017 · Cited by 80
Peng, Z., Chen, L., Nussler, A. K., Liu, L., & Yang, W. Q. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3428 · Cited by 75
Self-citationMitostasis, Calcium and Free Radicals in Health, Aging and Neurodegeneration
Godoy, J. A., Ríos, J. A., Picón-Pagès, P., Herrera-Fernández, V., Swaby, B., Crepin, G., Vicente, R., Fernández‐Fernández, J. M., & Muñoz, F. J. (2021) · Biomolecules · doi:10.3390/biom11071012 · Cited by 73
Tasnim, F., Phan, D., Toh, Y., & Yu, H. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.002 · Cited by 73
Nelson, L. J., Morgan, K., Treskes, P., Samuel, K., Henderson, C., LeBled, C., Homer, N. Z. M., Grant, M. H., Hayes, P. C., & Plevris, J. N. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12631 · Cited by 73
Deng, J., Zhang, X., Chen, Z., Luo, Y., Lu, Y., Liu, T., Wu, Z., Yu, J., Zhao, W., & Lin, B. (2019) · Biomicrofluidics · doi:10.1063/1.5070088 · Cited by 72
Li, F., Cao, L., Parikh, S., & Zuo, R. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.02.021 · Cited by 72
Kandel, B. A., Thomas, M., Winter, S., Damm, G., Seehofer, D., Burk, O., Schwab, M. G., & Zanger, U. M. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.03.007 · Cited by 71
Self-citationInfluence of Liver Fibrosis on Lobular Zonation
Ghallab, A., Myllys, M., Holland, C. H., Zaza, A., Murad, W., Hassan, R. A. R. A., Ahmed, Y. A., Abbas, T., Abdelrahim, E. A., Schneider, K. M., et al. (2019) · Cells · doi:10.3390/cells8121556 · Cited by 74
Self-citationŠtampar, M., Breznik, B., Filipič, M., & Žegura, B. (2020) · Cells · doi:10.3390/cells9122557 · Cited by 70
Liver cell therapy: is this the end of the beginning?
Alwahsh, S. M., Rashidi, H., & Hay, D. C. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2713-8 · Cited by 71
The future of phenotypic drug discovery
Berg, E. L. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.01.010 · Cited by 69
Sarkar, U., Ravindra, K. C., Large, E. M., Young, C. L., Rivera‐Burgos, D., Yu, J., Cirit, M., Hughes, D. J., Wishnok, J. S., Lauffenburger, D. A., et al. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074005 · Cited by 69
Xie, J., Yang, L., Tian, L., Li, W., Yang, L., & Li, L. (2016) · Scientific Reports · doi:10.1038/srep27665 · Cited by 69
Tolosa, L., Gómez-Lechón, M. J., López, S. A., Guzmán, C., Castell, J. V., Donato, M. T., & Jover, R. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw078 · Cited by 69
Self-citationContextualizing Hepatocyte Functionality of Cryopreserved HepaRG Cell Cultures
Jackson, J. P., Li, L., Chamberlain, E., Wang, H., & Ferguson, S. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.069831 · Cited by 67
Theobald, J., el Maaty, M. A. A., Kusterer, N., Wetterauer, B., Wink, M., Cheng, X., & Wölfl, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-40851-9 · Cited by 68
A liver-chip-based alcoholic liver disease model featuring multi-non-parenchymal cells
Deng, J., Chen, Z., Zhang, X., Luo, Y., Wu, Z., Lu, Y., Liu, T., Zhao, W., & Lin, B. (2019) · Biomedical Microdevices · doi:10.1007/s10544-019-0414-9 · Cited by 67
Štampar, M., Tomc, J., Filipič, M., & Žegura, B. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02576-6 · Cited by 68
Rebelo, S. P., Costa, R., Estrada, M. F., Shevchenko, V., Brito, C., & Alves, P. M. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1320-9 · Cited by 66
Davidson, M. D., Kukla, D. A., & Khetani, S. R. (2017) · Integrative Biology · doi:10.1039/c7ib00027h · Cited by 67
Qiu, W., Yang, M., Liu, J., Xu, H., Luo, S., Wong, M. H., & Zheng, C. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.11.039 · Cited by 66
Engineering Liver Microtissues for Disease Modeling and Regenerative Medicine
Huang, D. (., Gibeley, S. B., Xu, C., Xiao, Y., Celik, O., Ginsberg, H. N., & Leong, K. W. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909553 · Cited by 65
Wang, X., Chang, C. H., Jiang, J., Liu, X., Li, J., Liu, Q., Liao, Y., Li, L., Nel, A. E., & Xia, T. (2020) · Small · doi:10.1002/smll.202000528 · Cited by 65
The comet assay applied to HepG2 liver spheroids
Elje, E., Hesler, M., Rundén‐Pran, E., Pascal, M., Mariussen, E., Wagner, S., Dušinská, M., & Kohl, Y. (2019) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2019.03.006 · Cited by 71
Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk
Daneshian, M., Kamp, H., Hengstler, J., Leist, M., & van de Water, B. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1698-7 · Cited by 65
Self-citationTutty, M. A., Movia, D., & Prina‐Mello, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01147-0 · Cited by 67
Human Induced Pluripotent Stem Cells in Hepatology
Gerbal‐Chaloin, S., Funakoshi, N., Caillaud, A., Gondeau, C., Champon, B., & Si‐Tayeb, K. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.09.026 · Cited by 69
Vivarès, A., Salle-Lefort, S., Arabeyre‐Fabre, C., Ngo, R., Pénarier, G., Bremond, M., Moliner, P., Gallas, J., Fabre, G., & Klieber, S. (2014) · Xenobiotica · doi:10.3109/00498254.2014.944612 · Cited by 64
Effect of early allograft dysfunction on outcomes following liver transplantation
Hudcova, J., Scopa, C., Rashid, J., Waqas, A., Ruthazer, R., & Schumann, R. (2016) · Clinical Transplantation · doi:10.1111/ctr.12887 · Cited by 64
Current limitations and future opportunities for prediction of DILI from in vitro
Funk, C., & Roth, A. B. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1874-9 · Cited by 63
In vitro assessment of hepatotoxicity by metabolomics: a review
Cuykx, M., Rodrigues, R. M., Laukens, K., Vanhaecke, T., & Covaci, A. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2286-9 · Cited by 67
Self-citationHepatic spheroids used as an in vitro model to study malaria relapse
Chua, A. C. Y., Ananthanarayanan, A., Ong, J. J. Y., Wong, J. Y., Yip, A., Singh, N. H., Qu, Y., Dembélé, L., McMillian, M., Ubalee, R., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.05.032 · Cited by 65
Lee-Montiel, F. T., Laemmle, A., Charwat, V., Lee, C. S., Lee, C. S., Huebsch, N., Okochi, H., HANCOCK, M. J., Siemons, B. A., Boggess, S. C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.667010 · Cited by 65
Best Practices and Progress in Precision-Cut Liver Slice Cultures
Dewyse, L., Reynaert, H., & van Grunsven, L. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137137 · Cited by 71
Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury
Lin, C., & Khetani, S. R. (2016) · BioMed Research International · doi:10.1155/2016/1829148 · Cited by 66
How predictive quantitative modelling of tissue organisation can inform liver disease pathogenesis
Drasdo, D., Hoehme, S., & Hengstler, J. G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.013 · Cited by 63
Self-citationA microphysiological system model of therapy for liver micrometastases
Clark, A. M., Wheeler, S., Taylor, D. P., Pillai, V. C., Young, C. L., Prantil‐Baun, R., Nguyen, T., Stolz, D. B., Borenstein, J. T., Lauffenburger, D. A., et al. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214532596 · Cited by 64
Bell, C. C., Chouhan, B., Andersson, L. C., Andersson, H., Dear, J. W., Williams, D. P., & Söderberg, M. P. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02682-w · Cited by 62
Kyffin, J. A., Sharma, P., Leedale, J., Colley, H. E., Murdoch, C., Mistry, P., & Webb, S. D. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.01.023 · Cited by 64
Metadata
- Authors
- Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., Braeuning, A., Budinsky, R. A., Burkhardt, B., Cameron, N. R., Camussi, G., Cho, C.-S., Choi, Y.-J., Craig Rowlands, J., Dahmen, U., Damm, G., Dirsch, O., Donato, M. T., Dong, J., Dooley, S., Drasdo, D., Eakins, R., Ferreira, K. S., Fonsato, V., Fraczek, J., Gebhardt, R., Gibson, A., Glanemann, M., Goldring, C. E. P., Gómez-Lechón, M. J., Groothuis, G. M. M., Gustavsson, L., Guyot, C., Hallifax, D., Hammad, S., Hayward, A., Häussinger, D., Hellerbrand, C., Hewitt, P., Hoehme, S., Holzhütter, H.-G., Houston, J. B., Hrach, J., Ito, K., Jaeschke, H., Keitel, V., Kelm, J. M., Kevin Park, B., Kordes, C., Kullak-Ublick, G. A., LeCluyse, E. L., Lu, P., Luebke-Wheeler, J., Lutz, A., Maltman, D. J., Matz-Soja, M., McMullen, P., Merfort, I., Messner, S., Meyer, C., Mwinyi, J., Naisbitt, D. J., Nussler, A. K., Olinga, P., Pampaloni, F., Pi, J., Pluta, L., Przyborski, S. A., Ramachandran, A., Rogiers, V., Rowe, C., Schelcher, C., Schmich, K., Schwarz, M., Singh, B., Stelzer, E. H. K., Stieger, B., Stöber, R., Sugiyama, Y., Tetta, C., Thasler, W. E., Vanhaecke, T., Vinken, M., Weiss, T. S., Widera, A., Woods, C. G., Xu, J. J., Yarborough, K. M., & Hengstler, J. G.
- Affiliations
- University of Zurich (CH)
- Leibniz Research Centre for Working Environment and Human Factors (DE)
- The Hamner Institutes for Health Sciences (US)
- Goethe University Frankfurt (DE)
- Vrije Universiteit Brussel (BE)
- University of Freiburg (DE)
- Leipzig University (DE)
- Dow Chemical (United States) (US)
- Durham University (GB)
- Seoul National University (KR)
- Instituto de Investigación Sanitaria La Fe (ES)
- Heidelberg University (DE)
- University of Liverpool (GB)
- University of Groningen (NL)
- Lund University (SE)
- University of Manchester (GB)
- South Valley University (EG)
- Heinrich Heine University Düsseldorf (DE)
- University Hospital Regensburg (DE)
- Merck KGaA, Darmstadt (Germany) (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Musashino University (JP)
- University Hospital Zurich (CH)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Hewitt, Nicola J.
- ORCID
- Hewitt, Nicola J.
- Andersen, Melvin E.
- Bhattacharya, Sudin
- Bode, Johannes Georg
- Borner, Christoph
- Böttger, Jan
- Braeuning, Albert
- Budinsky, Robert A.
- Cameron, Neil R.
- Camussi, Giovanni
- Cho, Chong-Su
- Choi, Yun-Jaie
- Dahmen, Uta
- Damm, Georg
- Dirsch, Olaf
- Donato, María Teresa
- Dong, Jian
- Dooley, Steven
- Drasdo, Dirk
- Gibson, Andrew
- Glanemann, Matthias
- Groothuis, Geny M. M.
- Hallifax, David
- Hammad, Seddik
- Hayward, Adam
- Häussinger, Dieter
- Hellerbrand, Claus
- Hewitt, Philip
- Hoehme, Stefan
- Holzhütter, Hermann-Georg
- Houston, J. Brian
- Ito, Kiyomi
- Jaeschke, Hartmut
- Keitel, Verena
- Kordes, Claus
- Kullak-Ublick, Gerd A.
- LeCluyse, Edward L.
- Maltman, Daniel J.
- McMullen, Patrick
- Merfort, Irmgard
- Meyer, Christoph
- Mwinyi, Jessica
- Naisbitt, Dean J.
- Nussler, Andreas K.
- Olinga, Peter
- Pampaloni, Francesco
- Pi, Jingbo
- Pluta, Linda
- Przyborski, Stefan A.
- Ramachandran, Anup
- Rogiers, Vera
- Schwarz, Michael
- Singh, Bijay
- Stelzer, Ernst H. K.
- Stieger, Bruno
- Sugiyama, Yuichi
- Vanhaecke, Tamara
- Vinken, Mathieu
- Weiss, Thomas S.
- Woods, Courtney G.
- Hengstler, Jan G.
- Venue
- Archives of Toxicology
- Published
- 2013-08
- Volume
- 87
- Issue
- 8
- Pages
- 1315-1530
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- PMC
- PMC3753504
- OpenAlex
- W2134520937
- Cited by
- 1,280
- References
- 1,862
- Citations by year
- 2026: 54 · 2025: 63 · 2024: 59 · 2023: 80 · 2022: 98 · 2021: 96 · 2020: 130 · 2019: 132 · 2018: 129 · 2017: 102 · 2016: 118 · 2015: 110 · 2014: 91 · 2013: 12
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Archives of Toxicology (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Durham Research Online (Durham University) (acceptedVersion, other-oa)
- Durham Research Online (Durham University) (submittedVersion, cc-by)
- HAL (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- University of Regensburg Publication Server (University of Regensburg)
- Funders
- Leibniz-Institut für Arbeitsforschung an der TU Dortmund
- Deutsche Forschungsgemeinschaft (GRK1104, (EXC 294))
- Agence Nationale de la Recherche
- Bundesministerium für Bildung und Forschung
- Belgian Federal Science Policy Office
- Fonds Wetenschappelijk Onderzoek
- National Research Foundation of Korea
- Innoviris
- Universität Regensburg
- Vlaamse regering
- National Institutes of Health (AA12916)
- Biotechnology and Biological Sciences Research Council (1233823)
- Leibniz-Gemeinschaft
- Japan Society for the Promotion of Science (23590204)
- National Institute on Alcohol Abuse and Alcoholism (R56AA012916, R01AA012916)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK070195)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Keywords
- hepatotoxicity, primary hepatocytes, non-parenchymal liver cells, hepatocyte co-culture, precision-cut liver slices, isolated perfused liver, stem cell-derived hepatocytes, induced pluripotent stem cell-derived hepatocytes, nuclear receptors, Ras/MEK/ERK pathway, HNF4α, drug metabolism, ADME, drug interactions
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Liver, Inactivation, Metabolic, Organ Culture Techniques, Signal Transduction, Receptors, Cytoplasmic and Nuclear, Toxicity Tests, Coculture Techniques, Hepatocytes, Toxicogenetics, Culture Techniques, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review